Allergy/Immunology · Saint George, UT
NPI
1568423879
Since 2006
Specialty
Allergy/Immunology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1490 E Foremaster Dr Ste 260
Saint George, UT, 84790
Phone (435) 688-1128
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
98,033 services
Medicare patients, 2024
516
Average age 73
Drug cost, 2024
$1.6M
2,224 prescriptions
Company payments, 2025
$2,051
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kenneth R Pinna was code J2356 (injection, tezepelumab-ekko, 1 mg), 66,161 times for 56 patients. In total Kenneth R Pinna billed 98,033 services in 24 codes, and Medicare paid $1.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 66,161 | 56 | $14.19 | $939K |
| 95004 Test - Miscellaneous | Office | 11,527 | 167 | $2.29 | $26K |
| J2357 Injection, omalizumab, 5 mg | Office | 10,535 | 34 | $29.01 | $306K |
| J0517 Injection, benralizumab, 1 mg | Office | 3,160 | 32 | $130.46 | $412K |
| 95165 Treatment - Miscellaneous | Office | 2,145 | 113 | $8.84 | $19K |
| 95115 Treatment - Miscellaneous | Office | 1,171 | 93 | $5.86 | $6,865 |
| 95044 Test - Miscellaneous | Office | 1,116 | 31 | $2.99 | $3,336 |
| 96372 Injection Administration | Office | 665 | 108 | $9.61 | $6,390 |
| 99213 Office E&M - Established | Office | 511 | 324 | $55.47 | $28K |
| 95117 Treatment - Miscellaneous | Office | 322 | 22 | $7.35 | $2,366 |
| 94010 Pulmonary Function Testing | Office | 270 | 169 | $16.79 | $4,534 |
| 99203 Office E&M - New | Office | 183 | 183 | $60.66 | $11K |
| 70486 CT/CTA - Head and Neck | Office | 84 | 77 | $86.18 | $7,239 |
| 94060 Pulmonary Function Testing | Office | 66 | 65 | $26.13 | $1,724 |
| 99443 Telephone Services | Office | 25 | 22 | $65.13 | $1,628 |
By year: 2022 $144K for 18,997 services; 2023 $137K for 18,748 services; 2024 $1.8M for 98,033 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kenneth R Pinna prescribed most often to Medicare patients was Montelukast Sodium, with 247 prescriptions and refills. In total Kenneth R Pinna wrote 2,224 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 247 | 433 | 63 | $2,069 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 206 | 256 | 43 | $161K |
| Azelastine Hcl Generic | 144 | 236 | 71 | $3,166 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 133 | 157 | 37 | $19K |
| Ipratropium Bromide Generic | 129 | 195 | 46 | $3,907 |
| Prednisone Generic | 128 | 147 | 85 | $338 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 127 | 167 | 60 | $3,241 |
| Azithromycin Generic | 107 | 136 | 45 | $909 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 79 | 91 | 21 | $57K |
| Fluticasone Propionate Generic | 64 | 97 | 25 | $736 |
| Cyproheptadine Hcl Generic | 50 | 58 | 19 | $479 |
| Breo Ellipta Fluticasone/Vilanterol | 46 | 66 | Under 11 | $26K |
| Gabapentin Generic | 39 | 57 | Under 11 | $715 |
| Hydroxyzine Hcl Generic | 39 | 51 | 21 | $491 |
| Triamcinolone Acetonide Generic | 38 | 38 | 25 | $112 |
Brand drugs: 714 claims; generic drugs: 1,510 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kenneth R Pinna $2,051 ($2,051 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $473.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 13 | $473 |
| Amgen Inc. AMGN | 4 | $332 |
| Genzyme Corporation SNY | 11 | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $205 |
| Genentech USA, Inc. ROG.SW | 4 | $109 |
| Regeneron Pharmaceuticals, Inc. REGN | 1 | $109 |
| Pfizer Inc. PFE | 4 | $102 |
| Grifols USA, LLC | 3 | $79.01 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $72.53 |
| BioCryst US Sales Co., LLC | 3 | $68.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.